Quince Therapeutics (QNCX) announced the settlement of the company’s outstanding obligations under its loan from the European Investment Bank for a payment of $5.5M. Effective immediately upon the $5.5M payment, Quince settled outstanding EIB debt obligations of approximately $16.4M as of March 27. As a direct result of this $5.5M payment, all of the company’s obligations under both the settlement agreement and the underlying loan agreement have been fully satisfied and discharged.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNCX: